New antivirals for Hepatitis C - what does the evidence prove?

There ’s been a lot of attention given to the new antirviral drugs which target Hepatitis C - partly because of the burden of infection of the disease, and the lack of a treatment that can be made easily accessible to around the world, and partly because of the incredible cost of a course of treatment. But a new article on BMJ talks about the...
Source: The BMJ Podcast - Category: General Medicine Authors: Source Type: podcasts